This document provides a collection of checklists that serve as a quick-reference communications and social mobilization guide on aspects of routine immunization and disease surveillance, in addition to supplementary immunization for polio …

Malaria is a leading cause of morbidity and mortality in children younger than 5 years in Kenya. Within the context of planning for a vaccine to be used alongside existing malaria control methods, this study, published in Malaria …

Malaria is a leading cause of mortality and morbidity in Mozambique, with nearly three-quarters of the country’s malaria-related deaths occurring in children younger than five years. A malaria vaccine is not yet available, but planning is …

This article, published in BMC Medicine, critically reviews available cost-effectiveness models for rotavirus vaccination, comparing their designs using a standardized approach and studying the similarities and differences in cost-effectiveness …

Published in Health Policy and Planning, this compares cost-of-illness (COI) with stated preference estimates of willingness-to-pay associated with shigellosis in a rural area of China to evaluate the economic benefits of disease …

This article, published in the journal Vaccine, presents data generated through a PATH-supported study that demonstrated safe and immunogenic coadministration of measles vaccine and the live, attenuated japanese …

This report provides a review of all aspects of influenza vaccine research and development, financing, manufacturing, efficacy, safety, regulatory issues, procurement, distribution, usage, public education, consumer acceptance, and public policy. …

This fact sheet highlights PATH's work to address rotavirus and includes general information about its efforts to increase access to and effectiveness of existing vaccines, as well as to develop new vaccines.

This WHO Guidance Note advocates for a comprehensive approach to cervical cancer prevention and control and is aimed at senior policy makers and programme managers. It describes the need to deliver effective interventions across the female life …

From 2006 to 2011, PATH conducted demonstration projects in four low- and middle-income countries—India, Peru, Uganda, and Vietnam—to provide evidence for decision-making about public-sector introduction of human papillomavirus (HPV) …

The Meningitis Vaccine Project (MVP) was established with the goal of developing, testing, licensing, and introducing an affordable group A meningococcal conjugate vaccine for Africa. The authors of this article, published in Vaccine, describe the …

Japanese encephalitis (JE) results in significant mortality and disability in children in Asia. In Indonesia, despite recognition of JE virus transmission, reports of human disease have been few and from limited geographic areas. Hospital-based …

This article, published in Tropical Medicine & International Health, asserts that surveillance systems and techniques for diagnosing bacterial meningitis and pneumococcal disease in the African meningitis belt have improved greatly over the …

This review, published in Expert Review of Vaccines, looks at what has been learned from developing conjugate vaccines against Haemophilus influenzae type b, Streptococcus pneumoniae, and group C Neisseria meningitidis that could be useful for the …

Many junior doctors today have not had occasion to treat a child for Hib disease. The remarkable absence of cases of this disease is due to the use of conjugate vaccines. In countries with established Hib vaccination programs the incidence of …

To assess whether certain serogroups of Streptococcus pneumoniae are preferentially associated with specific disease manifestations, we analyzed all recent pneumococcal disease studies and assessed the relative frequency of isolation of each …

These guidelines, designed for physicians, laboratory workers, and health care administrators, provide comprehensive information on epidemiology and standard techniques for diagnosis, treatment, prevention, and control of meningococcal disease …

The article, from the New England Journal of Medicine, provides an up-to-date summary of JE disease incidence, epidemiology, and vaccines against JE.

This supplemental issue of Clinical Infectious Diseases provides numerous articles on the surveillance and detection of pneumococcal and Haemophilus influenzae type b disease in developing countries. Topics include progress and challenges in disease …

This article, published in the journal Vaccine, reviews potential correlates of protection against influenza and discusses some of the vaccination strategies that could result in optimal protection against epidemic and pandemic influenza. ABSTRACT …

The authors of this article, published in PLoS ONE, applied cost-effectiveness modeling and a cold-chain impact assessment to aid decision-making on rotavirus vaccine introduction in Kenya. They conclude that use of either vaccine is cost-effective, …

This report from the WHO's Weekly Epidemiologic Record summarizes a meeting convened by PATH, WHO, and the US Centers for Disease Control and Prevention (CDC) on the economic burden of rotavirus disease and cost-effectiveness of vaccines. The …

This article, published in Value in Health, discusses a study to develop a cost function model to estimate the public treatment cost of shigellosis patients in Thailand. The study was an incidence-based cost-of-illness …

Published in the Journal of Pharmaceutical Finance, Economics & Policy, this article evaluates the potential use of vaccines against Japanese encephalitis (JE) and estimates the cost-effectiveness of mass vaccination campaigns and routine …

This study, published in the journal Pediatrics, examines the costs and benefits of routine rotavirus vaccination for infants in the US, using a hypothetical cohort of unvaccinated infants. Researchers determined that, at current prices, …